CYP2B6 c.171+6241A>G

Variant ID: 19-41503622-A-G

NM_000767.4(CYP2B6):c.171+6241A>G

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Whole genome sequencing identifies high-impact variants in well-known pharmacogenomic genes.

The Pharmacogenomics Journal
Choi, Jihoon J; Tantisira, Kelan G KG; Duan, Qing Ling QL
Publication Date: 2019-04

Variant appearance in text: rs7250873
PubMed Link: 30214008
Variant Present in the following documents:
  • NIHMS1503453-supplement-3.xlsx, sheet 1
View BVdb publication page



Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa.

British Journal Of Clinical Pharmacology
Sinxadi, Phumla Z PZ; Leger, Paul D PD; McIlleron, Helen M HM; Smith, Peter J PJ; Dave, Joel A JA; Levitt, Naomi S NS; Maartens, Gary G; Haas, David W DW
Publication Date: 2015-07

Variant appearance in text: rs7250873
PubMed Link: 25611810
Variant Present in the following documents:
  • Main text
View BVdb publication page



Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians.

Pharmacogenetics And Genomics
Bertrand, Julie J; Chou, Monidarin M; Richardson, Danielle M DM; Verstuyft, Céline C; Leger, Paul D PD; Mentré, France F; Taburet, Anne-Marie AM; Haas, David W DW; ,
Publication Date: 2012-12

Variant appearance in text: rs7250873
PubMed Link: 23104099
Variant Present in the following documents:
  • Main text
View BVdb publication page